Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

Well, if you have to ask Blue...it seems folks are beginning to realize there's no way out of this mess before a reverse split (probably at 25:1) AND more dilution. I believe they will happen in very quick succession. After that, the market looks even more unfavorably on ADXS and it further sinks.
But all is not lost...it is at this point I'll rebuy. AIM2CERV should be a success and the vaccine approved. Moreover, pediatric osteo will also eventually be approved. I think (ok...hope!) this is the last rs and dilution before an approval. But you never know.